1. |
Lata J. Diagnosis and treatment of autoimmune hepatitis[J]. Dig Dis, 2012, 30(2): 212-215.
|
2. |
Longhi MS, Ma Y, Mieli-Vergani G, et al. Aetiopathogenesis of autoimmune hepatitis[J]. J Autoimmun, 2010, 34(1): 7-14.
|
3. |
Invernizzi P. Geoepidemiology of autoimmune liver diseases[J]. J Autoimmun, 2010, 34(3): 300-306.
|
4. |
Czaja AJ. Autoimmune liver disease and rheumatic manifestations[J]. Curr Opin Rheumatol, 2007, 19(1): 74-80.
|
5. |
Donaldson PT. Genetics in autoimmune hepatitis[J]. Semin Liver Dis, 2002, 22(4): 353-364.
|
6. |
Czaja AJ, Bianchi FB, Carpenter HA, et al. Treatment challenges and investigational opportunities in autoimmune hepatitis[J]. Hepatology, 2005, 41(1): 207-215.
|
7. |
Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol, 1999, 31(5): 929-938.
|
8. |
Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis[J]. Hepatology, 2008, 48(5): 1540-1548.
|
9. |
Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis[J]. Hepatology, 2008, 48(1): 169-176.
|
10. |
Feld JJ, Dinh H, Arenovich T, et al. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome[J]. Hepatology, 2005, 42(1): 53-62.
|
11. |
Gleeson D, Heneghan MA, British society of gastroenterology.British society of gastroenterology (BSG) guidelines for management of autoimmune hepatitis[J]. Gut, 2011, 60(12): 1611-1629.
|
12. |
Czaja AJ. Features and Consequences of untreated type 1 autoimmune hepatitis[J]. Liver Int, 2009, 29(6): 816-823.
|
13. |
Trivedi PJ, Hirschfield GM. Treatment of autoimmune liver disease: current and future therapeutic options[J]. Ther Adv Chronic Dis, 2013, 4(3): 119-141.
|
14. |
Manns MP, Woynarowski M, Kreisel W, et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis[J]. Gastroenterology, 2010, 139(4): 1198-1206.
|
15. |
Montano-Loza AJ, Carpenter HA, Czaja AJ. Consequences of treatment withdrawal in type 1 autoimmune hepatitis[J]. Liver Int, 2007, 27(4): 507-515.
|
16. |
Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis[J]. Hepatology, 2010, 51(6): 2193-2213.
|
17. |
Hirschfield GM, Al-Harthi N, Heathcote EJ. Current status of therapy in autoimmune liver disease[J]. Therap Adv Gastroenterol, 2009, 2(1): 11-28.
|
18. |
Kaplan MM, Gershwin ME. Primary biliary cirrhosis[J]. N Engl J Med, 2005, 353(12): 1261-1273.
|
19. |
Lleo A, Battezzati PM, Selmi C, et al. Is autoimmunity a matter of sex?[J]. Autoimmun Rev, 2008, 7(8): 626-630.
|
20. |
Selmi C, Invernizzi P, Zuin M, et al. Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology[J]. Semin Liver Dis, 2005, 25(3): 265-280.
|
21. |
Invernizzi P, Selmi C, Mackay IR, et al. From bases to basis: linking genetics to causation in primary biliary cirrhosis[J]. Clin Gastroenterol Hepatol, 2005, 3(5): 401-410.
|
22. |
Invernizzi P, Gershwin ME. The genetics of human autoimmune disease[J]. J Autoimmun, 2009, 33(3-4): 290-299.
|
23. |
Selmi C, Gershwin ME. The role of environmental factors in primary biliary cirrhosis[J]. Trends Immunol, 2009, 30(8): 415-420.
|
24. |
European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases[J]. J Hepatol, 2009, 51(2): 237-267.
|
25. |
Crosignani A, Battezzati PM, Invernizzi P, et al. Clinical features and management of primary biliary cirrhosis[J]. World J Gastroenterol, 2008, 14(21): 3313-3327.
|
26. |
Cullen SN, Chapman RW. The medical management of primary sclerosing cholangitis[J]. Semin Liver Dis, 2006, 26(1): 52-61.
|
27. |
Maggs JR, Chapman RW. An update on primary sclerosing cholangitis[J]. Curr Opin Gastroenterol, 2008, 24(3): 377-383.
|
28. |
Lazaridis KN, Gores GJ. Primary sclerosing cholangitis and cholangiocarcinoma[J]. Semin Liver Dis, 2006, 26(1): 42-51.
|
29. |
Silveira MG, Lindor KD. Clinical features and management of primary sclerosing cholangitis[J]. World J Gastroenterol, 2008, 14(21): 3338-3349.
|
30. |
Vogel A, Wedemeyer H, Manns MP, et al. Autoimmune hepatitis and overlap syndromes[J]. J Gastroenterol Hepatol, 2002, 17(Suppl 3): 389-398.
|
31. |
Czaja AJ. The overlap syndromes of autoimmune hepatitis[J]. Dig Dis Sci, 2013, 58(2): 326-343.
|
32. |
Mieli-Vergani G, Vergani D. Autoimmune paediatric liver disease[J]. World J Gastroenterol, 2008, 14(21): 3360-3367.
|